Elevated serum substance P level as a predictive marker for moderately emetogenic chemotherapy‐induced nausea and vomiting: A prospective cohort study

Chemotherapy‐induced nausea and vomiting (CINV) is an unbearable side effect. Identifying high emetic risk patients and providing more active antiemetics strategies are mandatory to improve the tolerability of chemotherapy. In this prospective cohort study, leptin, ghrelin, and substance P were meas...

Description complète

Enregistré dans:
Détails bibliographiques
Publié dans:Cancer Med
Auteurs principaux: Park, Hyung Soon, Won, Hye Sung, An, Ho Jung, Cho, Sung Shim, Kim, Hyun Ho, Sun, Der Sheng, Ko, Yoon Ho, Shim, Byoung Yong
Format: Artigo
Langue:Inglês
Publié: John Wiley and Sons Inc. 2020
Sujets:
Clinical Cancer Research
Accès en ligne:https://ncbi.nlm.nih.gov/pmc/articles/PMC7897939/
https://ncbi.nlm.nih.gov/pubmed/33369184
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1002/cam4.3693
Tags: Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!

Documents similaires